Thinard, R.; Farkas, A.E.; Halasa, M.; Chevalier, M.; Brodaczewska, K.; Majewska, A.; Zdanowski, R.; Paprocka, M.; Rossowska, J.; Duc, L.T.;
et al. “Endothelial Antibody Factory” at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases. Pharmaceutics 2022, 14, 1418.
https://doi.org/10.3390/pharmaceutics14071418
AMA Style
Thinard R, Farkas AE, Halasa M, Chevalier M, Brodaczewska K, Majewska A, Zdanowski R, Paprocka M, Rossowska J, Duc LT,
et al. “Endothelial Antibody Factory” at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases. Pharmaceutics. 2022; 14(7):1418.
https://doi.org/10.3390/pharmaceutics14071418
Chicago/Turabian Style
Thinard, Reynald, Attila E. Farkas, Marta Halasa, Melanie Chevalier, Klaudia Brodaczewska, Aleksandra Majewska, Robert Zdanowski, Maria Paprocka, Joanna Rossowska, Lam Tri Duc,
and et al. 2022. "“Endothelial Antibody Factory” at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases" Pharmaceutics 14, no. 7: 1418.
https://doi.org/10.3390/pharmaceutics14071418
APA Style
Thinard, R., Farkas, A. E., Halasa, M., Chevalier, M., Brodaczewska, K., Majewska, A., Zdanowski, R., Paprocka, M., Rossowska, J., Duc, L. T., Greferath, R., Krizbai, I., Van Leuven, F., Kieda, C., & Nicolau, C.
(2022). “Endothelial Antibody Factory” at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases. Pharmaceutics, 14(7), 1418.
https://doi.org/10.3390/pharmaceutics14071418